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ABSTRACT: Organoselenium compounds are a new class of emerging potent antioxidants. Basically, their rational 
design and synthesis was aimed at mimicking the native glutathione peroxidase enzyme in their reduction of 
hydroperoxides at the expense of the ubiquitous antioxidant, glutathione. In this review, emphasis was focused on 
the seemingly antagonistic mechanisms employed by organoseleniums under in vitro and in vivo conditions. 
Summarily, in vitro evidences clearly demonstrate that the pharmacological effect of organoseleniums strictly 
depends on their GPx mimic. However, these selenium based compounds evoke an increase in the level of 
endogenous thiols suggesting a possible switch in their glutathione peroxidase mimic under in vivo conditions. 
Apparently, this mechanistic switch is puzzling and requires concerted efforts to unravel. 
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IN SELENOPROTEINS – THE MAKING OF 
POTENT NUCLEOPHILES 
Selenium, named after the Greek Goddess of the moon, 
Selene was first discovered in 1817 by the Swedish chemist 
Jöns Jacob Berzelius (Comasseto 2010; Nogueira and Rocha, 
2010). This element shares some chemical properties with 
sulfur and tellurium. But biologically speaking, selenium 
shares some properties with sulfur and their sulfhydryl and 
their selenohydryl and sulfhydryl groups (Figure 1) can be 
considered two important soft nucleophile center classes in 
cell (note that sulfhydryl or thiol and selenohydryl or selenol 
groups are soft analogs of the hard analog hydroxyl group, 
see Figure 1 for comparisons). 
It is a common knowledge in the scientific community 
that selenium is an essential dietary trace element for 
mammals (Zwolak and Zaprowska, 2012; Loef et al., 2011; 
Harthill, 2011; Soni et al., 2010; Brozmanova et al., 2010). 
Essentially, selenium is a component of selenoproteins 
found in most living things. For examples, vertebrates have 
about 2 to 3 dozens of selenoproteins (Lobanov et al. 2007, 
2009). In vertebrates, selenium can be considered as a 
“supersulfur”, when present in the form of a selenol (R-SeH; 
Scheme 1), which is a softer and stronger nucleophile than  
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its thiol analogue (Nogueira and Rocha 2010). Selenol 
groups are considerably less abundant than thiol groups and 
are found in a very small number of selenoproteins (Lobanov 
et al. 2007, 2009; Araie and Shiraiwa 2009). These findings 
suggest that excess of thiolate over selenolate groups cannot 
replace selenium in cell physiology. 
GLUTATHIONE – AN IMPORTANT UBIQUITOUS 
ANTIOXIDANT 
At this point, it should be noted that the role played by 
selenium in different classes of prokaryote and eukaryote 
cannot be viewed as a simple substitution of the sulfur 
analogue as exemplified in Fig.  1. Generally, in the case of 
mammals, one of the most important soft nucleophiles 
found in cells and in the extracellular fluids is the sulfhydryl 
group (thiol/thiolate; Figure 1), which can be found in the 
low-molecular-weight compounds such as cysteine and 
glutathione or in high-molecular-weight proteins. The 
concentration of low-molecular-weight thiols can be as high 
as 5–10 mmol/L, depending on the tissue considered (Maciel 
et al. 2000). Of these low molecular weight thiols, it is 
worth mentioning that glutathione (GSH, γ-L-glutamyl-L-
cysteinylglycine) is a predominant intracellular thiol 
compound and one of the most important antioxidants in  
FIGURE 1 Nitration Structures of serine, cysteine (thiol-thiolate form) and 
selenocysteine (selenol-selenolate form). 
SCHEME 1 Comparison between thiol/thiolate and selenol/selenolate groups.  Selenol group is a 
stronger soft nucleophile than an analog thiol. Selenol groups are also more acidic than the thiol groups 
by about 3 orders of magnitude (compare the pka of each group). 
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the central nervous system. It is present in cytoplasm, 
nucleus and mitochondria of neurons and exerts effects on 
receptor function (such as NMDA receptor), and apoptosis 
regulation. GSH reacts indirectly with radicals, such as 
superoxide radical, nitric oxide and hydroxyl radical. 
Moreover, it is an electron donor in reactions catalyzed by 
glutathione peroxidase (GPx). Glutathione can also 
covalently interact with different proteins and can modulate 
the thiol-containing-proteins functioning via a 
glutathionylation reaction  (For a comprehensive review of 
the physiological role of glutathione see Drigen, 2000; 
Garcia-Garcia et al. 2012; Markovic et al. 2010; Naoi et al. 
2009;  Wu et al. 2004; Cotgrave 2003). 
SELENIUM INCORPORATION INTO 
SELENOPROTEINS 
Major milestones along the course of identification that 
selenium is an element with biological functions were the 
biochemical confirmation that the mammalian glutathione 
peroxidase was a selenoprotein (Flohe et al. 1973; Rotruck et 
al. 1973) and selenium atom is present in selenoproteins in 
the form of selenocysteine in rat liver glutathione peroxidase 
(Forstrom et al. 1978). Thereafter, it was determined that all 
selenoproteins contain at least one selenocysteinyl residue 
in their structures (Lu and Holmgren 2009; Lobanov et al. 
2009). The incorporation of a selenium in selenoproteins is 
complex and requires different enzymatic steps and 
complex macromolecular components (including a specific 
t-RNA charged with serine (t-RNA[Ser]Sec), the 
selenocysteine insertion sequence (SECIS) element located 
in the 3´-untranslated region of the mRNA of the 
selenoprotein, and protein factors such as elongation factor 
EFSec and the SECIS binding protein 2, SBP2; see Bock et al. 
1991).  
Indeed, the extremely high chemical reactivity of 
selenocysteine precludes its existence as free amino acid in 
aerobic cell environment. Thus, to circumvent this chemical 
problem, the machinery of synthesis of selenoproteins has 
evolved as an expansion of the genetic code and the UGA 
codon, which is a termination code, codifies for a 
selenocysteine. However, here we must emphasize that this 
occurs only when UGA is present within the RNA 
sequences of a given selenoprotein (Allmang et al. 2009).   
Selenocysteine is formed by the incorporation of Se from 
selenophosphate in O-phosphoseryl-tRNA([Ser]Sec). 
Consequently, the serine residue is transformed in 
selenocysteine and the hard nucleophile group –OH is 
transformed in the soft nucleophile group -SeH (Allmang et 
al. 2009) and physiologically there is no a free pool of 
selenocysteine. 
SCHEME 2 The Generic reactions catalyzed by glutathione peroxidase (GPx). GPx isoforms can decompose 
different peroxydes (including hydrogen peroxide, organic peroxides and peroxynitrite) forming non-toxic 
products. 
Kade & Rocha            Pharmacology of organoselenium compounds          Biokemistri 24(1):1-14 
4 
THE SELENOPROTEINS – EMPHASIS ON 
GLUTATHIONE PEROXIDASE  
The glutathione peroxidase (EC 1.11.1.19) is an important 
selenoprotein that has a direct bearing on our review. This 
enzyme catalyzes the reduction of a variety of 
hydroperoxides (ROOH and H2O2) using GSH as a 
reductant. More recently, Sies and collaborators have 
obtained persuasive experimental points of evidence 
demonstrating that GPx1 (cytosolic glutathione peroxidase) 
can decompose peroxynitrite in vitro (Scheme 2; Sies and 
Arteel, 2000; Mugesh et al., 2001). However, the 
physiological role of GPx1 as a modulator of peroxynitrite 
level has not yet been demonstrated. In addition, there are at 
least six seleno-glutathione peroxidase isoenzymes 
identified in mammals, so far, differing in many properties, 
including their localization, subunit number, global 
structure, primary structure, and enzymatic properties. 
Although, their expression is ubiquitous, the levels of which 
isoform vary, depending on the tissue type. The classical 
cellular glutathione peroxidase (GPX1 or cGPX), found in 
cytosolic space and mitochondria, reduces fatty acid 
hydroperoxides and H2O2. Phospholipid hydroperoxide 
glutathione peroxidase (GPX4 or PHGPX), found in most 
tissues and located in both the cytosol and the membrane 
fraction, can directly reduce the phospholipid 
hydroperoxides, fatty acid hydroperoxides, and cholesterol 
hydroperoxides that are produced in peroxidized 
membranes and oxidized lipoproteins. Finally, cytosolic 
glutathione peroxidase (GPX2 or GIGPX) and extracellular 
glutathione peroxidase (GPX3 or eGPX) are rarely detected 
in most tissues except for the gastrointestinal tract and 
kidney (Tapiero et al., 2003; Luo et al., 2003). Considering 
the importance of glutathione peroxidase activity, the 
enzymatic catalytic cycle was studied by the Flohe and 
Wendel groups (Flohe et al., 1973; Flohe, 1989; Wendel et al., 
1975; Wendel et al., 1984). Thus, they demonstrated that 
glutathione peroxidase catalyzes the reduction of H2O2 at 
the expense of GSH. As illustrated in Figure 2, the selenol 
group (-SeH) of a reduced selenocysteine molecule is 
oxidized by the hydroperoxides to generate a selenenic acid. 
The tripeptide GSH then reacts with the selenenic acid, 
resulting in the corresponding water and selenenyl sulfide. 
A second molecule of GSH attacks the sulfur in the latter 
species, producing disulfide and regenerating the selenol to 
complete the catalytic cycle (Flohe, 1989; Wendel et al., 
1975). 
Since glutathione peroxidase catalyzes the reduction of a 
wide variety of hydroperoxides and together with GSH 
constitutes a powerful cellular defense system against so-
called oxidative stress, considerable efforts have been made 
to find compounds capable of imitating the enzymatic  
FIGURE 2 The catalytic mechanism of the native glutathione peroxidase. The cycle of the enzyme 
highlights the role of oxidation of its selenol group (-SeH) to selenenic acid (-SeOH) that is 
sequentially reduced by GSH to regenerate the native reduced enzyme. 
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properties of glutathione peroxidase. This becomes crucial 
considering some shortcomings of the administration of 
native GPx with therapeutic objectives, including instability 
and poor availability. Consequently, the high molecular 
weight of native GPx limits its therapeutic application. 
Therefore, considerable efforts have been made to find 
organoselenium compounds capable of imitating the 
enzymatic properties of glutathione peroxidase and free of 
these aforementioned shortcomings. In this context, several 
research groups have developed a number of small 
molecules, including substituted diselenides, N-Se 
heterocycles, and other type of organoselenium compounds 
with glutathione peroxidase-like activity (Bhabak and 
Mugesh 2010). It is also worth mentioning that 
semisynthetic enzymes, obtained by enzyme engineering, 
have been proposed as mimics of glutathione peroxidase 
(Luo et al., 2003; Ren et al., 2002). Our focus in this review 
is on the synthetic organoselenium compounds with 
glutathione peroxidase mimic and we will give emphasis to 
ebselen and diphenyl diselenide, two compounds that have 
GPx-like activity (Wilson et al. 1989) and have been found 
to exert antioxidant and protective effects in different in 
vitro and in vivo models of toxicity (Nogueira and Rocha, 
2010; 2011). We want to emphasize that for an 
organoselenium compound to exhibit antioxidant 
properties, it must show nucleophilicity necessary for 
glutathione peroxidase-like activity, potential free radical 
scavenger activity, and low toxicity.  To imitate native GPx, 
organoselenium compounds are thought to be transformed 
into selenol intermediates either via reduction by thiol or via 
NADPH-dependent enzymatic reduction by hepatic and 
cerebral thioredoxin reductase (Figure 3; De Freitas and 
Rocha 2011) Consequently, the rational synthesis, 
pharmacological testing and toxicological evaluations of 
organoselenium compounds have been quite an arduous 
task (Nogueira and Rocha 2010). 
DEVELOPMENT OF SYNTHETIC 
ORGANOSELENIUM COMPOUNDS WITH GPX 
MIMICS 
The identification of selenocysteine in the active center of 
hepatic rat glutathione peroxidase in the laboratory of 
Tappel in 1978 brought to scene the softest nucleophile 
group found in the biological system, i.e., the selenol group 
(Tappel, 1978; Pierce and Tappel, 1978). Selenol groups are 
powerful reducing components of antioxidant enzymes such 
as glutathione peroxidase and thioredoxin reductase (Lu 
and Holmgren 2009; Nogueira and Rocha 2010, 2011). 
Following this, a number of organoselenium compounds 
have been synthesized and tested as a mimetics of GPx 
(Muller et al. 1984; Wendel et al. 1984; Parham and Kindt, 
1984). Ebselen was the first organoselenium with  
FIGURE 3 Reduction of Ebselen and Diphenyl Diselenide by a direct interaction with Reduced Glutathione or by an indirect 
Reduction Mediated by Thioredoxin Reductase (TrxR). The mammalian TrxR uses the electron equivalents derived from 
NADPH to reduce Ebselen and Diselenide. The formation of the selenol intermediates (pink and blue coloured groups) of 
these compounds is crucial for their thiol-peroxidase like activity that can decompose efficiently different peroxides. 
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demonstrable GPx-like activity, requiring reduced 
glutathione or other reduced thiols to catalyze the reduction 
decomposition of a wide variety of hydroperoxides (Figure 
4) (Parnham and Kindt 1984; Wendel et al. 1984; Müller et 
al. 1984). The mechanism of ebselen mediated 
decomposition of peroxides have been described to be 
kinetically similar to that of GPx reaction (compare Figures 
2 and 4; Maiorino et al. 1988). First, ebselen reacts with the 
thiols to generate a selenenyl sulfide. The selenenyl sulfide 
reacts with a second equivalent of GSH to yield a selenol 
intermediate. Finally, the selenol reacts with H2O2 or 
organic hydroperoxide to form H2O or the respective alcohol 
(ROH) and ebselen selenenic acid. While GSH is an 
important thiol for ebselen GPx mimic (Maiorino et al. 1988; 
Haenen et al. 1990), it is important to point out that in 
contrast to the reaction catalyzed by the enzyme, which 
contains binding sites conferring substrate specificity, 
ebselen and other organoselenium compounds can utilize a 
variety of thiols with varying degree of efficiency (Engman 
et al. 1992; Iwaoka and Tomoda 1994; Mugesh et al. 2001). In 
addition to ebselen, another class of organoselenium 
compounds worth mentioning is the diorganyl diselenides 
(see Figure 4). Among the diorganyl diselenides, diphenyl 
diselenide (DPDS) has been well studied. (Nogueira et al., 
2004, Nogueira and Rocha, 2010, 2011) and the schematic 
GPx mimic is presented in Figure 4. The decade of the 
1990s was characterized by an enormous development in the 
field of small synthetic organoselenium compounds that 
mimic glutathione peroxidase catalytic activity, such as 
benzoselenazinones (Jacquemin et al. 1992), 
benzoselenazolinones (Galet et al. 1994), camphor-derived 
selenenamide (Back and Dick 1997), 2-
phenylselenenylnaphthol (Engman et al. 1995), alfa-
(phenylseleny) ketones (Engman et al. 1994), and oxygen-
containing diselenides (Wirth, 1998). Moreover, a number of 
attempts have been made to design and synthesize ebselen-
related GPx mimics based on substituent effects or isosteric 
replacements, most of them met with limited success. 
Ebselen derivatives, such as benzisochalcogenazolones, 
contain intramolecular interactions as Se-O and 
consequently increased the catalytic activity of ebselen. For 
FIGURE 4 Thiol peroxidase-like Activity of Ebselen (left) and Diphenyl Diselenide (Right). Ebselen and diselenide showing 
their chemical structure and their derivatives during the catalytic detoxification of H2O2 done at the expenses of reducing 
equivalents derived from GSH (adapted from Nogueira et al. 2004). 
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instance, benzisoselenazolones N-alkyl substituted were 
more active than ebselen. However, benzisoselenazolone N-
phenyl substituted showed lower peroxidase activity than 
ebselen, which could be attributed to its poor solubility. 
CONSTRAINTS TO GPX MIMIC OF 
ORGANOSELENIUMS 
In Figure 4, we can observe that the GPx mimic activity of 
ebselen depends on the reduction of the selenenic acid to 
selenol by thiols. This raises two vital questions: Is the GPx 
mimic efficiency of a specific organoseleniums strictly 
dependent on critical thiol type? Is the GPx mimic catalytic 
efficacy of any organoselenium compound critically 
dependent on the nature of the peroxides? Elegant findings 
by Mugesh and his collaborators provided insight to these 
questions. They observed that any substituent that is 
capable of enhancing the nucleophilic attack of thiol at 
sulfur in the selenenyl sulfide intermediate would enhance 
the antioxidant potency of ebselen and other 
organoselenium compounds. It was demonstrated that the 
use of thiol having an intramolecular coordinating group 
would enhance the biological activity of ebselen. On the 
other hand, they observed that the nature of the peroxide 
has little effect on the catalytic efficiencies (Bhabak and 
Mugesh 2007). However, other authors observed that 
electronic and steric effects have profound influence on the 
GPx-like activity of ebselen. The incorporation of a 
substituent ortho to the selenium atom sterically hinders 
the attack of a nucleophile at selenium, prevents thiol 
exchange reactions, and promotes the production of selenol, 
the GPx-active form, and thus, the GPx-like activity is 
greatly enhanced. This study further demonstrated that the 
electronic nature of the substituent groups is less important 
than their steric effects to the peroxidase-like activity 
(Pearson and Boyd 2008). 
Taking a holistic view of the considerations above, 
Sarma and Mugesh in 2008 postulated a revised mechanism 
for the GPx-mimetic activity of ebselen. Considering the 
complications associated with the catalytic mechanism of 
ebselen and that none of the intermediates other than the 
selenenyl sulfides have been confirmed, a reversible 
cyclization pathway was demonstrated. This study shows 
the first structural evidence that the seleninic acid, which 
was never proposed as an intermediate in the catalytic 
mechanism of ebselen, is the only stable and isolable 
product in the reaction of ebselen with peroxides. 
PHARMACOLOGICAL IMPLICATION OF THE GPX 
MIMIC OF ORGANOSELENIUMS 
From the foregoing, it is apparent that at least some 
organoselenium compounds are capable of performing the 
redox cycle of glutathione peroxidase, with the property of 
imitating the redox physiological chemistry of 
selenol/selenolate groups. Consequently, specific 
selenocompounds (such as diphenyl diselenide and ebselen) 
might supplement natural cellular defenses against the 
oxidizing agents especially in mammalian systems. 
Therefore, synthetic organoselenium compounds could 
represent a novel therapeutic approach to target diseases 
where oxidative stress plays a role (Arteel and Sies, 2001). 
For an organoselenium compound to be an antioxidant, it 
must show nucleophilicity necessary for imitating 
glutathione peroxidase, potential free radical scavenger 
activity, and low toxicity. In this way, pharmacological 
research with organoselenium compounds has provided 
fascinating challenges in dose–response relationships 
because of its contrasting behavior that is dose dependent 
(Nogueira and Rocha, 2010). At this point, we focused on 
the pharmacological implications of the GPx mimic of 
synthetic organoseleniums, with emphasis on their 
antioxidants effects.   
In the last four decades, the antioxidant or 
organoselenium compounds have been reported in different 
in vitro experimental models (Hermenegildo et al. 1990; 
Christison et al. 1994; Rossato et al. 2002a; Tiano et al. 2003; 
Andersson et al. 1994; Rossato et al. 2002b; Meotti et al. 




3(2H)-one, and bis(2-aminophenyl) diselenide) were 
screened for antioxidant activity in human blood platelets. 
Among these compounds, only bis(2-aminophenyl) 
diselenide inhibited lipid peroxidation. Bis(2-aminophenyl) 
diselenide was also effective in preventing the generation of 
oxidized low-molecular-weight thiols (GSH, cysteine CSH, 
cysteinylglycine CGSH) in platelets (Saluk-Juszczak et al. 
2006). Ebselen and other organoselenium compounds can 
potentially react with peroxynitrite, an extremely reactive 
nitrogen species (NS) and a potent pro-inflammatory agent 
(Masumoto and Sies 1996; Masumoto et al. 1996). 
Accordingly, peroxynitrite (ONOO) is a strong electrophile 
that is produced by the reaction of nitric oxide and 
superoxide anion. Consequently, uncontrolled generation of 
peroxynitrite, normally causes exacerbate oxidation of 
critical biomolecules that is accompanied by an intensive 
destruction of host cellular constituents.  For instance, 
peroxynitrite causes the nitration of tyrosyl residues of 
specific proteins (Figure 5) and can disrupt the 
physiological function of oxidized protein (Figure 5; d’Ischia 
et al. 2012; Castro et al. 2011;  Butterfield et al. 2011). 
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The reaction of diselenides with peroxynitrite has not been 
demonstrated. However, diaryl diselenides, diphenyl 
diselenide and p-chlorodiphenyl diselenide (in analogy to 
ebselen) inhibited lipid peroxidation induced by sodium 
nitroprusside, which can be a consequence of their reaction 
with nitric oxide or peroxynitrite formed from its oxidation 
(Rossato et al. 2002b). However, detailed studies about the 
reaction of diselenides (and selenolate intermediates formed 
after reduction by GSH or other reduced thiols) are highly 
desirable to determine the affinity of these forms towards 
the cytotoxic peroxynitrite.  Of particular pharmacological 
significance, diphenyl diselenide can reduce the oxidation 
and nitration found in a model of atherosclerosis in mice 
(Hort et al. 2011), indicating that diphenyl diselenide can 
reduce the toxicity of peroxynitrite to the endothelial cell in 
mice that do not express ApoE receptor. 
EVIDENCE OF GPX MECHANISTIC SWITCHING BY 
ORGANOSELENIUMS IN VIVO 
Consequent from the GPx mimic described above, it is 
apparent that in mammals, the pharmacological effect of 
organoselenium compounds will depend on the ubiquitous 
antioxidant tripeptide, glutathione to effect their 
pharmacological actions. In fact several in vitro models have 
consistently shown that the GPx mimic is the critical 
mechanisms for organsoselenium (For excellent reviews, see 
Mugesh et al., 2001, Nogueira et al., 2004, Nogueira and 
Rocha 2010, 2011). In our lab, we have demonstrated that 
organic moiety of organoselenium compounds can have 
profound effect on their GPx mimic. In this regard, we 
compared diphenyl diselenide and dicholesteroyl diselenide, 
the latter having a bulky organic moiety than the former 
(Kade et al., 2008). In that report, we observed that diphenyl 
diselenide exhibited marked GPx mimc than dicholesteroyl 
diselenide. Similarly, diphenyl diselenide exerted strong in 
vitro antioxidant effect in several models of oxidative stress 
than dicholesteroyl diselenide. Furthermore, reports have 
shown that diverse organoseleniums with differential GPx 
mimic exerted differential pharmacological potencies. In 
this regard, p-chlorodiphenyl diselenide, diphenyl 
diselenide, and diethyl diselenide were more catalytic than 
ebselen. Diselenides, p-aminodiphenyl diselenide, and 
dibutyl diselenide had poor GPx-like activity, while p-
methoxyldiphenyl diselenide and dipropyl diselenide had no 
effect (Meotti et al. 2004; Wilson et al. 1989). Strict 
FIGURE 5 Nitration of proteins by peroxynitrite: Inhibition by Ebselen. Protein nitration can cause loss of 
physiological function of a given protein. Ebselen can inhibit protein nitration via a direct interaction with 
peroxynitrite. 
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dependence of organoseleniums on GSH as a substrate for 
their GPx mimic rather than other thiols is apparent in the 
light of our observation and other authors wherein the GPx 
activity of ebselen and related compounds were studied to 
understand the reason for the relatively poor catalytic 
activity of these compounds in aromatic thiol assays 
(Parnham and Graf, 1987; Mugesh et al., 2001, Nogueira et al., 
2004). The reaction of ebselen with thiophenyl (PhSH) does 
not generate any selenol even when an excess amount of 
thiol is used. Although the Se-N bond in ebselen is readily 
cleaved by PhSH to produce the selenenyl sulfide, the 
reaction of selenenyl disulfide with PhSH does not produce 
the selenol. This is due to the presence of strong Se · · ·O 
nonbonded interactions in the selenenyl sulfide, which 
facilitates an attack of thiol at selenium rather than at sulfur, 
leading to thiol exchange reaction (Parnham and Graf, 1987). 
This undesired thiol exchange reaction hampers the 
formation of selenol. Further studies also indicate that the 
nature of thiol has a dramatic effect on the catalytic 
activities of these ebselen analogues. On the other hand, as 
mentioned above, the nature of peroxides does not appear to 
have any significant effect on the catalytic efficiencies. 
Therefore, the discrepancies in the activities of 
organoselenium compounds in various assays should arise 
mainly from the variation in thiol used for the reduction of 
hydroperoxides.  
Apparently, the GPx mimic of organoselenium accounts 
for most of their observed pharmacological effect. At this 
point, we could speculate that the pharmacological activity 
of organoseleniums may generate a diminished level of 
glutathione as well as other thiols levels in physiological 
systems. Therefore, under in vivo conditions, we expect that 
the antioxidant efficacy of any organoselenium, much like 
the native GPx, will largely depend on the availability of the 
endogenous tripeptide, GSH.  However, under in vivo 
conditions and even under various conditions of oxidative 
stress related disease models where the level of GSH is 
generally compromised, administration of organoselenium 
compounds generally elevated the physiological level of the 
tripeptide, GSH. This is a paradox and a puzzle with respect 
to the chemistry of organoselenium compounds. This review 
will now focus on data obtained by several authors vis-à-vis 
the in vivo effects of organoselenium compounds with a view 
to illustrate this puzzling phenomenon. We want to 
emphasize that our focus will be tailored towards the 
influence of organoselenium compounds on the level of the 
endogenous thiols especially GSH.            
At this point, we want to review data obtained by 
several authors with respect to the relationship of 
organoseleniums and level of endogenous thiols under in vivo 
conditions. In the study of Pawlas and Maecki, (2007), they 
observed that under combined conditions of normoxia and 
ischemia, ebselen (1 - 20 µM) increased the level of 
intracellular GSH (126.49 ± 9.46% - 144.52 ± 9.84% 
respectively). However, under ischemic condition alone, 
ebselen increased GSH level in the range (157.02 ± 18.09 - 
119.35 ± 12.00%). It would be observed that under normoxia, 
higher doses of ebselen exerted more pronounced effects, 
while in ischemia, the opposite effect was observed. These 
authors argued that one possible explanation for this 
observed effect is that the increase in GSH level after 
ebselen administration could be at least partially explained 
by the decreased GSH consumption caused by 
strengthening of antioxidative mechanisms. They concluded 
that ebselen administration probably replaces ischemia-
inactivated GPx activity, thereby contributing to reduction 
of GSH consumption and diminution of oxidative stress. In 
another report, Wistar rats were treated with 7,12-
dimethylbenz[a]anthracene (DMBA) and the 
organoselenium compounds [1- isopropyl-3-
methylbenzimidazole-2-selenone (Se I) and 1, 3-di-p-
methoxybenzylpyrimidine-2-selenone (Se II)] in determined 
doses. They observed that administration of rats with 
DMBA significantly resulted in decreased amount of total 
GSH levels in these rats and that the antioxidant activities 
and total GSH levels were significantly increased with 
administration of the organoselenium compounds (Talas et 
al., 2009a,b). In the work of Kiersztan and collaborators, 
they observed that diabetes induced a decrease in GSH level 
accompanied by a rise in GSSG content; hence GSH/GSSG 
ratio in diabetic was 50% lower than the value achieved in 
control animals. However, this condition was reversed by an 
organoselenium, methyl-selenocysteine where they observed 
that blood GSH level in diabetic animals increased by about 
40%, following methyl-selenocysteine administration, 
consequently resulting in an elevation of GSH/GSSG ratio. 
This effect of methylselenocysteine was attributed to its 
ability to interfere with the enzyme γ-glutamylcysteine 
synthetase (Kiersztan et al., 2009). In our group, we have 
also investigated the effect of organoseleniums on diabetes 
and glutathione homeostasis. For example, we have reported 
that diet supplementation of diphenyl diselenide positively 
influenced total hepatic –SH groups in diabetic rats. In fact, 
diabetes in these rats caused a reduction of about 23% in the 
hepatic –SH levels. Ingestion of diphenyl diselenide 
supplemented diet caused a significant increase in hepatic –
SH both in diabetic and non-diabetic rats. In addition, level 
of –SH in erythrocytes was markedly increased by diphenyl 
diselenide in both diabetic and non-diabetic rats (Barbosa et 
al., 2008a). 
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In fact, we have shown that route of administration, 
vehicle solution can greatly influence the pharmacology of 
organoselenium compounds (Kade et al., 2010). Therefore we 
again tested subcutaneous administration (pharmacological 
dose 1 mg/kg body weight) or acute 10 mg/kg body weight 
(Barbosa et al., 2008b) of either ebselen and diphenyl 
diselenide in diabetic rats (Barbosa et al., 2006). We 
observed that diphenyl diselenide treatment promoted per se 
a significant increase on hepatic, renal and blood GSH levels 
compared to control group. Similarly, in diabetic rats 
treated with the organoselenium, diphenyl diselenide, there 
was an elevated GSH levels in liver and kidney. In addition, 
oral administration of diphenyl diselenide in soya bean oil 
greatly increased the otherwise diabetic depleted hepatic 
GSH levels in rats, and diphenyl diselenide promoted a 
significant increase in hepatic, renal and spleen GSH levels. 
Also in the brain, diabetes also caused a noticeable 
diminution in the level of cerebral GSH and treatment with 
diphenyl diselenide evoked a significant sparing effect on 
the levels of GSH in the diabetic rat brain (Kade et al., 
2009a,b). 
From the foregoing, we observed that under in vivo 
conditions, organoselenium compounds evoked a marked 
increase in the level of endogenous thiols such as GSH. This 
is a puzzling in view of the generally acclaimed GPx mimic 
organoseleniums. In a stride to explain this observed 
phenomenon, we explored other possible antioxidant 
mechanisms that may be critical to pharmacology of 
organoseleniums in different physiological states and in this 
case, we studied diphenyl diselenides. Although there are 
few published studies on molecular mechanisms involved in 
diphenyl diselenide antioxidant property, we further 
confirmed that diphenyl diselenide generally exert its 
antioxidant action by mimicking glutathione peroxidase. 
Therefore, the effect of pH on GPx mimic activity and other 
possible mechanisms involved in the diphenyl diselenide 
antioxidant activity were investigated. On the one hand, 
diphenyl diselenide had neither free radical-scavenging nor 
Fe2+-chelating ability. However, diphenyl diselenide 
exhibited increasing ability to reduce Fe3+ with increasing 
pH. It is possible to hypothesize that the formation of stable 
selenolate ions increases the reducing property of this 
molecule and its antioxidant property. On the other hand, 
the GPx-like activity of diphenyl diselenide was maximum 
at neutral pH diminished in the acidic medium. 
Furthermore, independent of the pH, diphenyl diselenide 
decreased deoxyribose degradation mediated by either 
hydrogen peroxide or Fe2+. This indicates that the 
antioxidant properties of diphenyl diselenide in the acidic 
medium may not be related to its GPx-like activity 
(Ogunmoyole et al. 2009; Hassan et al. 2009a, b, c, d). 
FURTHER EVIDENCE OF MECHANISTIC GPX 
MIMIC SWITCHING BY ORGANOSELENIUM IN 
VIVO  
In fact, there are ample indirect evidences that indicate that 
there is a possible switch in the GPx mimic activity of 
organoseleniums chemistry under in vivo conditions. In this 
regard, the interaction of these classes of antioxidants with 
thiol containing proteins is worth mentioning. The 
sulfhydryl enzymes such as Na+/K+-ATPase (also known as 
the sodium pump), delta aminolevulinic acid dehydratase, 
lactate dehydrogenase are sensitive to conditions of 
oxidative stress via the inactivation of their thiols.  In our 
laboratory, we have observed that under in vitro conditions, 
organoselenium such as diphenyl diselenide inhibits 
sulfhydryl enzymes (Nogueira and Rocha, 2004, 2010, 2011). 
In fact of note is the fact that the inhibitory effect of these 
organoselenium compounds is in the micromolar range 
(Borges et al., 2005, Kade et al., 2008, 2009c). In order to 
establish the involvement of thiols in the inhibitory effect of 
organoselenium compounds on the activity of these 
sulfhydryl enzymes, exogenous thiols such as dithiothreitol 
have been used to recover the inhibition imposed by 
organoseleniums (Borges et al., 2005, Kade et al., 2008). 
Consequently, we can speculate that under in vivo 
conditions organoselenium compounds will have strong 
inhibitory effect on the activities of this class of enzymes. 
However, elegant experimental data have consistently 
shown that under in vivo conditions, organoselenium 
compounds protects these sulfhydryl enzymes especially 
under conditions of oxidative stress. In this regard, we 
reported that when mice were injected subcutaneously with 
diphenyl diselenide or dicholesteroyl diselenide previously 
dissolved in soya bean oil at chronic doses of 0.5 mmol kg⁻¹ 
body weight for four consecutive days, the activities of 
cerebral Na+/K+-ATPase were not markedly inhibited by 
both diselenides, suggesting that this cerebral enzyme may 
not be a molecular target of organodiselenides toxicity. We 
equally observed in this study that the administration of 
these organoseleniums in mice is accompanied by elevated 
levels of GSH. Generally when these enzymes were 
evaluated in models of oxidative stress related diseases such 
as diabetes wherein their levels were consistently decreased, 
we equally consistently observed that organoselenium 
interventions improves the activities of these enzymes with 
concomitant increase in the level of endogenous thiols 
evaluated as glutathione (Kade et al., 2009, 2009a, 2010; 
Barbosa et al., 2006, 2008). From these data and others 
(Nogueira and Rocha, 2011), we observed that the increase 
in the levels of these endogenous thiols necessitated by 
organoselenium intervention is suggestive and possibly 
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indicate that organoseleniums do not employ the classical in 
vitro GPx mimic activity to effect their pharmacological 
action under in vivo conditions. 
GPX MIMIC OF ORGANOSELENIUMS: PRE OR POST 
METABOLISM IN VIVO? 
In the light of the above and data obtained by other 
authors, we further argue that there is a strong but complex 
dynamics associated with the chemistry of organoselenium 
compounds under in vitro and in vivo conditions. Data 
obtained from studies conducted on lower organisms with 
organoseleniums suggests that in these organisms, they 
probably exhibited strong GPx-mimic. For example, the 
effect of diphenyl diselenide on GSH antioxidant capacity in 
a total radical trapping antioxidant parameter (TRAP) assay 
was studied by Zafarullah and his collaborators in yeast 
strains and they found that diphenyl diselenide attenuated 
the GSH antioxidant TRAP pattern in a time-dependent 
manner when an equimolar concentration of diphenyl 
diselenide and GSH is used, suggesting that it may react 
with GSH, forming an inactive adduct. They equally 
observed that when diphenyl diselenide was incubated with 
N-acetyl cysteine, the latter was able to neutralize and 
revert the pro-oxidant effect of diphenyl diselenide. They 
reasoned that diphenyl diselenide may either stimulate the 
increase of endogenous GSH biosynthesis or by a direct 
reaction with the drug (Zafarullah et al., 2003). We equally 
want to emphasize that at higher doses, organoselenium 
compounds can be toxic and this effect can be accompanied 
by decreased level of glutathione in animal tissues. A study 
by Rosa and collaborators (Rosa et al., 2005, 2007) may 
illustrate this point. In their work, they investigated the 
possible genotoxic effect of diphenyl diselenide in multiple 
organs (brain, kidney, liver, spleen, testes and urinary 
bladder) and tissues (bone marrow, lymphocytes) of mice 
using in vivo comet assay. They observed that the 
genotoxicity of diphenyl diselenide is accompanied with 
decreased glutathione in tissues tested. Equally, pre-
treatment of animals with N-acetyl-cysteine completely 
prevented diphenyl diselenide induced oxidative damage by 
the maintenance of cellular GSH levels, reinforcing the 
positive relationship of diphenyl diselenide induced GSH 
depletion and DNA damage.  
Consequently, we conclude that the pharmacological 
mechanism of organoseleniums whether in vitro or in vivo can 
be complex and is dependent on so many factors that are far 
from being fully understood. In this review, we have 
observed that although the utilization of glutathione in the 
antioxidant action of organoseleniums appears to be their 
major antioxidant mechanism, we speculate that the 
glutathione peroxidase mimic activity of organoseleniums 
shift depending on multifactorial considerations. It is 
noteworthy however, that the antioxidant action of 
organoseleniums in vivo may involve the activity of the non-
organic moiety of these organoseleniums. Consequently, 
there may be a sequential biotransformation of 
organoseleniums generating diverse intermediates and with 
each intermediate product utilizing diverse, but potent 
antioxidant mechanism which would apparently exclude 
glutathione peroxidase mimic that require the utilization of 
endogenous glutathione or other thiols. Equally, these 
metabolic intermediates may have some forms of positive 
interaction with the pathway leading to glutathione 
synthesis in vivo. 
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